Noxopharm Investigating Potential COVID-19 Treatment
1 April 2020 Noxopharm (NOX:ASX) announces that the Hudson Institute of Medical Research (Hudson Institute) in Melbourne has identified that idronoxil inhibits a key inflammatory pathway involved in a process known as a cytokine storm. Cytokine storm is…
Remote Internships for Masters Students – Can your organisation assist?
3 April 2020 The COVID-19 outbreak has led to unfortunate circumstances – some of which have affected student internships in the Master of Biomedical and Health Sciences at Monash University. Placements were secured, however a lot of them…
Where are we at with developing a vaccine for coronavirus?
3 April 2020 This article is republished from The Conversation under a Creative Commons license. Read the original article. Shutterstock Kylie Quinn, RMIT University and Damian Purcell, The Peter Doherty Institute for Infection and Immunity SARS-CoV-2, the virus…
New international collaboration showcases drug development potential
3 April 2020 New research from Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with the Max Planck Institute, Mayo Clinic, University of Auckland, University of Essex and University of Tokyo, has uncovered new structures of protein receptors,…
CSIRO begins testing Covid-19 vaccines
2 April 2020 CSIRO, Australia’s national science agency, has commenced the first stage of testing potential vaccines for COVID-19. The testing, expected to take three months, is underway at CSIRO’s high-containment biosecurity facility, the Australian Animal Health Laboratory…
BCG vaccine trial to protect Australian healthcare workers has begun, enabled by major philanthropic backing
2 April 2020 News at a Glance The BRACE trial to test whether BCG vaccination reduces the impact of COVID-19 has begun in Melbourne 300 staff at the Melbourne Children’s Campus of the planned 4000 healthcare workers across…
Australians 65 and older become first in the world to access FLUAD® Quad
2 April 2020 Australians 65 and older have become the first in the world to access FLUAD® Quad (adjuvanted quadrivalent influenza vaccine) following addition to the National Immunisation Program in 2020(1) FLUAD® Quad is a new vaccine that…
Impact of COVID-19 on Product Development: Information and Resource from Halloran
2 April 2020 Read the full statement from Halloran here. Halloran has formed a company-wide task force to curate information on the impact to the life science industry due to the current COVID-19 environment. We are leveraging our…
2020 GSK Award for Research Excellence: Nominations Now Open
2 April 2020 GSK are delighted to invite nominations for the 40th anniversary year of the GSK Award for Research Excellence. Presented annually since 1980, the Award acknowledges outstanding Australian researchers and provides an $80,000 (tax free) independent…
Skills Australia – Essential industry survey: biopharmaceutical and medical technology manufacturing industry (lodged by Tijan Ventures & BioMelbourne Network)
Posted to web – 31 March 2020 Lodged by Tijan Ventures & BioMelbourne Network 27 March 2020 Julie Stratford Industry Engagement Manager Skills Impact By Email Dear Julie, Essential industry survey: biopharmaceutical and medical technology manufacturing industry The…
The Pratt Foundation commits $1 million to support clinical trials for COVID-19 treatments
31 March 2020 The Doherty Institute has welcomed a generous commitment of $1 million from Anthony Pratt and The Pratt Foundation, which will be directed towards the Australasian COVID-19 Trial (ASCOT). Led by the Royal Melbourne Hospital’s infectious…
Australian Museum Eureka Prizes 2020 – Deadline Extended!
31 March 2020 (Entries close 15 May 2020 – deadline extended) The Australian Museum Eureka Prizes are the country’s most comprehensive national science awards, honouring excellence across the areas of research & innovation, leadership, science engagement, and school…
